PharmaCyte Biotech, Inc.

NASDAQ:PMCB

1.6 (USD) • At close December 24, 2024
Bedrijfsnaam PharmaCyte Biotech, Inc.
Symbool PMCB
Munteenheid USD
Prijs 1.6
Beurswaarde 11,149,008
Dividendpercentage 0%
52-weken bereik 1.39 - 2.58
Industrie Biotechnology
Sector Healthcare
CEO Mr. Joshua N. Silverman
Website https://pharmacyte.com

An error occurred while fetching data.

Over PharmaCyte Biotech, Inc.

PharmaCyte Biotech, Inc., a biotechnology company, focuses on developing and commercializing cellular therapies for cancer, diabetes, and malignant ascites in the United States. Its cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types of cancer, including advanced

Vergelijkbare Aandelen

OKYO Pharma Limited logo

OKYO Pharma Limited

OKYO

1.065 USD

Aspira Women's Health Inc. logo

Aspira Women's Health Inc.

AWH

0.772 USD

BioSig Technologies, Inc. logo

BioSig Technologies, Inc.

BSGM

1.48 USD

Freeline Therapeutics Holdings plc logo

Freeline Therapeutics Holdings plc

FRLN

6.49 USD

Modular Medical, Inc. logo

Modular Medical, Inc.

MODD

1.32 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)